JP2014518542A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518542A5 JP2014518542A5 JP2013555539A JP2013555539A JP2014518542A5 JP 2014518542 A5 JP2014518542 A5 JP 2014518542A5 JP 2013555539 A JP2013555539 A JP 2013555539A JP 2013555539 A JP2013555539 A JP 2013555539A JP 2014518542 A5 JP2014518542 A5 JP 2014518542A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- plant
- composition
- protein hydrolyzate
- glp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 48
- 239000003531 protein hydrolysate Substances 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 31
- 108010064851 Plant Proteins Proteins 0.000 claims description 27
- 235000021118 plant-derived protein Nutrition 0.000 claims description 27
- 101800001982 Cholecystokinin Proteins 0.000 claims description 14
- 102100025841 Cholecystokinin Human genes 0.000 claims description 14
- 229940107137 cholecystokinin Drugs 0.000 claims description 14
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 13
- 229920001184 polypeptide Polymers 0.000 claims description 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 230000003578 releasing effect Effects 0.000 claims description 11
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 claims description 10
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims description 10
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 claims description 10
- 235000021374 legumes Nutrition 0.000 claims description 10
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 230000002797 proteolythic effect Effects 0.000 claims description 5
- 230000004936 stimulating effect Effects 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 4
- 230000036186 satiety Effects 0.000 claims description 4
- 235000019627 satiety Nutrition 0.000 claims description 4
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims 1
- 229940071440 soy protein isolate Drugs 0.000 description 7
- 108010073771 Soybean Proteins Proteins 0.000 description 5
- 108010019160 Pancreatin Proteins 0.000 description 4
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- 235000021120 animal protein Nutrition 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 229940055695 pancreatin Drugs 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 229940001941 soy protein Drugs 0.000 description 3
- 235000019710 soybean protein Nutrition 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161445593P | 2011-02-23 | 2011-02-23 | |
| US61/445,593 | 2011-02-23 | ||
| PCT/US2012/026250 WO2012141795A1 (en) | 2011-02-23 | 2012-02-23 | Protein hydrolysate compositions having enhanced cck and glp-1 releasing activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014518542A JP2014518542A (ja) | 2014-07-31 |
| JP2014518542A5 true JP2014518542A5 (enExample) | 2015-04-09 |
Family
ID=46001711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013555539A Pending JP2014518542A (ja) | 2011-02-23 | 2012-02-23 | 改善されたｃｃｋおよびｇｌｐ−１放出活性を有するタンパク質加水分解組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130331315A1 (enExample) |
| EP (1) | EP2677885A1 (enExample) |
| JP (1) | JP2014518542A (enExample) |
| CN (1) | CN103561589A (enExample) |
| BR (1) | BR112013021468A2 (enExample) |
| CA (1) | CA2825119A1 (enExample) |
| MX (1) | MX2013009772A (enExample) |
| WO (1) | WO2012141795A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2948003B1 (en) | 2013-01-23 | 2020-03-18 | Bottled Science Limited | Skin enhancing beverage composition |
| CN105164149A (zh) * | 2013-01-28 | 2015-12-16 | 索莱有限责任公司 | 具有饱腹感激素释放活性的新型多肽 |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| CN108271917A (zh) | 2013-03-08 | 2018-07-13 | 艾斯姆食品公司 | 大米蛋白补充剂 |
| MX387503B (es) * | 2013-03-11 | 2025-03-18 | Burcon Nutrascience Mb Corp | Producción de producto de proteína de legumbre. |
| CN105637096A (zh) * | 2013-10-04 | 2016-06-01 | 英诺威有限公司 | 动物蛋白质的水解产物、其制造方法及其用途 |
| US20160309755A1 (en) * | 2013-12-09 | 2016-10-27 | Abbott Laboratories | Nutritional compositions containing rice protein together with pea and/or potato proteins |
| CN105476030A (zh) * | 2015-12-15 | 2016-04-13 | 北京天肽生物科技有限公司 | 一种多功能复合低聚肽营养粉 |
| US11129404B2 (en) | 2015-12-28 | 2021-09-28 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
| EP3634155A4 (en) | 2017-05-12 | 2021-02-17 | Axiom Foods Inc. | RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION |
| WO2019081706A1 (en) * | 2017-10-26 | 2019-05-02 | Basf Se | PROTEIN HYDROLYSATES AS EMULSIFIERS FOR BAKERY PRODUCTS |
| DE112019005445T5 (de) | 2018-10-30 | 2021-07-15 | Michael Foods, Inc. | Knuspriges proteinhaltiges lebensmittelprodukt |
| JP7722183B2 (ja) * | 2019-05-08 | 2025-08-13 | 不二製油株式会社 | 食肉加工食品及びその製造方法 |
| JP7326022B2 (ja) * | 2019-05-17 | 2023-08-15 | ユニ・チャーム株式会社 | ペットフード |
| MX2022004904A (es) * | 2019-10-25 | 2022-08-10 | Supplant Foods Llp | Un proceso para preparar harina de garbanzos. |
| JP7282269B2 (ja) * | 2020-07-02 | 2023-05-26 | サントリーホールディングス株式会社 | ビールテイスト飲料 |
| CN117529235A (zh) * | 2021-04-12 | 2024-02-06 | 诺维信公司 | 用于生产人造肉产品的方法 |
| EP4201220A1 (en) * | 2021-12-24 | 2023-06-28 | Compagnie Gervais Danone | Plant-based composition and process of preparing the same |
| US20230292803A1 (en) * | 2022-01-21 | 2023-09-21 | Premier Nutrition Company, Llc | Sweetener composition and resultant beverage product |
| CN116082451B (zh) * | 2022-12-16 | 2024-08-27 | 上海理工大学 | 一种荞麦源促胆囊收缩素分泌肽及其制备方法和应用 |
| CN120732163A (zh) * | 2025-08-25 | 2025-10-03 | 北京幸福能量健康科技有限公司 | 提高glp-1激素分泌控制食欲的蛋白质膳食纤维组合物制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR7904209A (pt) | 1978-07-04 | 1980-06-17 | Novo Industri As | Preparacao de protease adequada para mistura a composicoes de lavagem processo para preparatease cepa de b licheniformis e composicao de lavagem |
| US5288627A (en) | 1988-01-07 | 1994-02-22 | Novo Nordisk A/S | Endoprotease from Fusarium oxysporumDSM 2672 for use in detergents |
| CA2003078A1 (en) | 1988-11-18 | 1990-05-18 | Alan Sloma | Protease deletion |
| DK19991D0 (da) | 1991-02-06 | 1991-02-06 | Novo Nordisk As | Proteinpraeparationer |
| DK63490D0 (da) | 1990-03-09 | 1990-03-09 | Novo Nordisk As | Fremgangsmaade til fremstilling af ost |
| JP3153237B2 (ja) | 1990-03-09 | 2001-04-03 | ノボ ノルディスク アクティーゼルスカブ | タンパク質加水分解物 |
| JP3046344B2 (ja) | 1990-10-24 | 2000-05-29 | 塩野義製薬株式会社 | 新規プロテアーゼ |
| DK52393D0 (enExample) | 1993-05-05 | 1993-05-05 | Novo Nordisk As | |
| DE69632630T2 (de) | 1995-03-16 | 2005-05-25 | Novozymes A/S | Enzym mit aminopeptidaseactivität |
| EP2336331A1 (en) | 1999-08-31 | 2011-06-22 | Novozymes A/S | Novel proteases and variants thereof |
| PL203212B1 (pl) | 2000-02-08 | 2009-09-30 | Dsm Ip Assets Bv | Zastosowanie trwałej w kwasie proteazy w karmie zwierzęcej oraz w wytwarzaniu kompozycji do stosowania w karmie zwierzęcej, dodatek do karmy zwierzęcej, kompozycja karmy zwierzęcej i sposób obróbki białek roślinnych |
| AU2003242695B2 (en) * | 2002-07-01 | 2007-12-06 | Unilever Plc | Satiety inducing composition |
| CA2507764A1 (en) * | 2002-12-20 | 2004-07-08 | Unilever Plc | Blood glucose regulating composition |
| CA2539693A1 (en) | 2003-10-10 | 2005-04-21 | Novozymes A/S | Protease variants |
| US20070190130A1 (en) * | 2006-02-16 | 2007-08-16 | Mark William A | Protein hydrolysate excipients |
| US9034402B2 (en) * | 2007-04-16 | 2015-05-19 | Solae, Llc | Protein hydrolysate compositions having improved sensory characteristics and physical properties |
| EP2052734A1 (en) * | 2007-10-26 | 2009-04-29 | Universiteit Maastricht | Proteins that stimulate the secretion of satiety hormones |
| FR2927335B1 (fr) * | 2008-02-12 | 2012-04-20 | Cie Des Peches Saint Malo Sante | Hydrolysat de proteines de poissons presentant une activite satietogene, compositions nutraceutiques et pharmacologiques comprenant un tel hydrolysat et procede d'obtention |
| CA2726110A1 (en) | 2008-06-20 | 2009-12-23 | Solae, Llc | Protein hydrolysate compositions stable under acidic conditions |
| EP2856885A3 (en) * | 2008-12-31 | 2015-05-27 | Solae, Llc | Protein hydrolysate compositions having enhanced cck releasing ability |
-
2012
- 2012-02-23 CA CA2825119A patent/CA2825119A1/en not_active Abandoned
- 2012-02-23 MX MX2013009772A patent/MX2013009772A/es not_active Application Discontinuation
- 2012-02-23 JP JP2013555539A patent/JP2014518542A/ja active Pending
- 2012-02-23 EP EP12716746.8A patent/EP2677885A1/en not_active Withdrawn
- 2012-02-23 CN CN201280010910.7A patent/CN103561589A/zh active Pending
- 2012-02-23 US US14/001,292 patent/US20130331315A1/en not_active Abandoned
- 2012-02-23 WO PCT/US2012/026250 patent/WO2012141795A1/en not_active Ceased
- 2012-02-23 BR BR112013021468A patent/BR112013021468A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014518542A5 (enExample) | ||
| Hernández-Ledesma et al. | ACE-inhibitory and radical-scavenging activity of peptides derived from β-lactoglobulin f (19− 25). Interactions with ascorbic acid | |
| WO2008101985A3 (en) | Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization | |
| WO2009147248A3 (en) | Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases | |
| HK1206761A1 (en) | Nutritive fragments, proteins and methods | |
| NZ602943A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| IN2012DN03368A (enExample) | ||
| WO2008142164A3 (en) | Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders | |
| EP4374913A3 (en) | Novel human serum albumin mutant | |
| WO2008074839A3 (en) | Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders | |
| HK1246097A1 (zh) | 含有壳多糖和可消化蛋白的组合物 | |
| MX2011007107A (es) | Composiciones de hidrolizado de proteina. | |
| WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
| WO2015006287A3 (en) | Compositions prepared from poultry and methods of their use | |
| EP4349359A3 (en) | Peptide exhibiting wrinkle-improving activity and uses thereof | |
| Huang et al. | Potato protein hydrolysate attenuates high fat diet-induced cardiac apoptosis through SIRT1/PGC-1a/Akt signalling | |
| RU2018138995A (ru) | Способы индуцирования и пролонгирования насыщения, уменьшения объёма и поглощения пищи, контроля веса и стимулирования снижения веса, пищевая композиция | |
| WO2009120837A3 (en) | Leucine-rich peptide compositions and methods for isolation | |
| JP2011137150A5 (enExample) | ||
| WO2015086686A3 (en) | Protease resistant peptides | |
| MX2020010807A (es) | Peptidos promotores del crecimiento y usos de los mismos. | |
| SG10201901656WA (en) | Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof | |
| WO2005082927A3 (en) | Antihypertensive peptides | |
| MXPA05012702A (es) | Productos alimenticios que incrementan la saciedad. | |
| NZ594481A (en) | Truncated cystine-knot proteins |